Liquidity & Technical

Liquidity & Technical

Figures converted from TWD at historical FX rates — see data/company.json.fx_rates (close to 0.035 USD per TWD across the price window). Ratios, percentages, technical indicators, and share counts are unitless and unchanged.

Msscorps trades with respectable absolute turnover ($48.7M of value per day on a 20-day basis) but with a 7.5% median daily range and 30-day realized volatility close to its five-year maximum, liquidity is the constraint — the impact cost, not the share count, is what stops a fund from sizing up cleanly. Technical stance is neutral with bullish trend bias: price sits 184% above the 200-day SMA and the 52-week high at $35.00 was printed only weeks ago, but the past five sessions gave back 20% as MACD rolled negative — a parabolic move in mid-correction.

1. Portfolio implementation verdict

2. Price snapshot

52-week range spans $4.04 to $35.00 — an 8.7-fold amplitude. The 1-year return is structural (post-AI-cycle re-rating); the 1-week return is −20% (a sharp pullback off the high). Both are true simultaneously and both matter for sizing.

3. The trend — price vs 50- and 200-day SMA (full price history)

Price is well above the 200-day SMA — current $27.30 versus 200-day at $9.61, a gap of approximately 184%. That is unambiguously an uptrend, but the gap itself is the warning: parabolic separations from the long-run mean revert. The 50-day SMA at $20.90 is the first level of structural support; losing it calls the move into question.

4. Relative strength

The data pipeline did not load broad-market or sector benchmark series for this ticker, so a side-by-side relative-strength line chart is omitted rather than fabricated. The raw absolute returns are the closest substitute and they are decisive on their own.

A 1-year total return above 560% materially dwarfs anything the TAIEX, MSCI Taiwan, or a semiconductor-services peer basket could plausibly have produced — relative strength is overwhelming on absolute terms. The relevant analytical question is no longer "is it outperforming?" but "how much of the move has already been claimed?"

5. Momentum — RSI(14) and MACD histogram (last 18 months)

RSI is 52.9 — back to neutral after spending most of February–April pinned above 70. That is the more important read than the raw level: the stock has unwound an overbought condition without a corresponding break in trend. MACD histogram, on the other hand, has flipped firmly negative (-0.74 on the latest print) and is widening to the downside — short-term momentum has rolled over. Net: neutral RSI plus negative-and-expanding MACD argues for "consolidation or deeper pullback" rather than "fresh leg up" over the next 4–8 weeks.

6. Volume, conviction, and the volatility regime

The three highest-volume sessions of the last two years all printed in late 2024 / early 2025 — before the parabolic leg — and were near-flat on the close. That is an institutional accumulation/redistribution signature rather than a panic-day signature. The 50-day average has stepped up roughly six-fold from a mid-2025 trough (about 0.3M shares) to current (2.6M shares), with the largest acceleration in February–March 2026 as the breakout triggered — the structural-sponsorship signal you want to see backing a multi-quarter move.

Current 30-day realized volatility is 112.8% annualized — within touching distance of the five-year maximum of 114.9%. The percentile bands for this name are p20 = 31% (calm), p50 = 39%, p80 = 55% (stressed); current realized is more than double the historical stressed threshold. The market is pricing extreme risk premium and a fund pricing exposure on options or on stop-loss assumptions should size accordingly.

7. Institutional liquidity panel

7A. ADV and turnover

ADV in absolute currency terms is healthy; the 60-day ADV (2.88M shares) is materially higher than the 20-day ADV (1.70M shares) — the most recent 20 sessions have actually traded lighter than the prior 60. That is the stamp of the pullback we are seeing on the price chart, and using 60-day ADV here would overstate the size a fund can move today.

7B. Fund-capacity table (capacity supports a fund up to this AUM)

7C. Liquidation runway

Because issuer-level market-cap data is missing, runway scenarios are expressed in absolute position-value terms rather than as percent of market cap:

7D. Price-range proxy

Median daily range over the last 60 sessions is 7.5% — well above the 2% threshold where impact cost stops being a rounding error. Combined with the realized-volatility regime above, a market order at 20% of session ADV should be assumed to move the print by 1–2% before clearing, and a meaningful build at 2% of the prior 20-day session ADV should be paced across multiple days with limit orders.

Bottom line on liquidity: a $70M position clears within five sessions at 20% ADV participation — that is the largest size we would recommend a fund try to build or exit inside a week. At the more conservative 10% ADV participation, the comparable five-session size is $35M. Anything materially above $175M (~19 sessions at 20% ADV) should be assumed to be a multi-week build and modeled as such.

8. Technical scorecard and stance

Stance: neutral with bullish trend bias on a 3–6 month horizon. The structural uptrend is intact — golden cross is six months old, sponsorship has stepped up sharply, and absolute relative-strength is overwhelming. But realized volatility is at its five-year ceiling and short-term momentum has rolled over while the stock sits 184% above its 200-day. Confirmation of the bullish case requires a reclaim and hold of $33.95 (just under the 52-week high — clearing it sets up a measured-move continuation). Invalidation lives at $21.00 — the 50-day SMA; losing it calls the parabolic leg over and opens a retest of the $13.70 100-day SMA or below. Liquidity is the constraint despite reasonable absolute turnover: with a 7.5% median daily range and vol near its five-year ceiling, the right action for a sub-$928M-AUM fund is build slowly over multiple weeks at the 10% ADV participation rate, not chase the next breakout.